{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:27Z","timestamp":1787027067772,"version":"build-2736575974"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Cellular senescence is a fundamental biological program that enforces a stable cell-cycle arrest in response to diverse stresses, acting as a crucial barrier against malignant transformation. In the context of prostate cancer, however, this protective mechanism paradoxically exhibits tumor-promoting potential under certain microenvironmental and therapeutic conditions. This review examines the various aspects of senescence in prostate cancer development, ranging from DNA damage\u2013 and oncogene-induced senescence (p53\/p21, PTEN\/p16, and RAS\/MYC) to treatment-induced senescence following androgen deprivation, radiotherapy, and chemotherapy. While senescence temporarily halts tumor formation via cell-intrinsic checkpoints and immune surveillance, overly persistent senescent cells trigger the development of a senescence-associated secretory phenotype (SASP) in which they secrete proinflammatory cytokines, chemokines, and proteases that modify the tumor microenvironment in ways that encourage inflammation, assist in the hyper-epithelial plasticity, and therapeutic resistance of the tumor. This review highlights new insights into the epigenetic control and metabolic rewiring that determine the shift between tumor-suppressing senescence and tumor-promoting senescence. This review consolidates the paradox of \u2018double-edged sword\u2019 senescence, delineating that its impact is contextually dependent on the cell, immune environment, and the duration of senescence. Finally, we discuss the predicted therapeutic approaches based on precision oncology to target and alter senescence using senolytics to eradicate aberrant senescent cells and senomorphics to target and adjust SASP. Addressing and regulating the plasticity of senescence is a significant and critical opportunity for improving the prognosis of prostate cancer, as well as guiding next-generation senescence-informed therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fonc.2026.1743564","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:18:32Z","timestamp":1771305512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The paradox of cellular senescence in prostate cancer: from tumor suppression to tumor promotion"],"prefix":"10.3389","volume":"16","author":[{"given":"Yitao","family":"Xing","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Yunnan University of Chinese Medicine","place":["Kunming, Yunnan, China"]},{"name":"China Joint Graduate School of Traditional Chinese Medicine","place":["Suzhou, China"]},{"name":"Hainan Hospital, Guangdong Provincial Hospital of Chinese Medicine","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozheng","family":"Qin","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Yunnan University of Chinese Medicine, Yunnan Provincial Hospital of Chinese Medicine","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Lin","sequence":"additional","affiliation":[{"name":"Hainan Hospital, Guangdong Provincial Hospital of Chinese Medicine","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Su","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiandong","family":"Lin","sequence":"additional","affiliation":[{"name":"Hainan Hospital, Guangdong Provincial Hospital of Chinese Medicine","place":["Haikou, China"]},{"name":"College of Traditional Chinese Medicine, Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifei","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Hainan Medical University","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3934\/molsci.2016.3.300","article-title":"Oxidative stress, cellular senescence and ageing","volume":"3","author":"Pole","year":"2016","journal-title":"AIMS Mol sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2024.13286","article-title":"Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge","volume":"30","author":"Jin","year":"2024","journal-title":"Mol Med Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2022.09.002","article-title":"Senescent stromal cells: roles in the tumor microenvironment","volume":"9","author":"Gabai","year":"2023","journal-title":"Trends Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13042","article-title":"Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer","volume":"15","author":"Chambers","year":"2021","journal-title":"Mol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000042886","article-title":"When therapy-induced senescence meets tumors: A double-edged sword: A review","volume":"104","author":"Liu","year":"2025","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/cells14130942","article-title":"Molecular regulation of SASP in cellular senescence: therapeutic implications and translational challenges","volume":"14","author":"Klepacki","year":"2025","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13578-022-00941-0","article-title":"Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer","volume":"12","author":"Kallenbach","year":"2022","journal-title":"Cell Biosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395047","article-title":"A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"B10","article-title":"Effects of Ras Oncoprotein and Growth Factors on the Cell Cycle Regulators Retinoblastoma Protein Rb and p2^ Cip1\/Waf1: Helsingin yliopisto","author":"Kivinen","year":"1999"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwx146","article-title":"cGAS-STING pathway in senescence-related inflammation","volume":"5","author":"Chen","year":"2018","journal-title":"Natl Sci Review"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70055","article-title":"Metabolic reprogramming in cancer and senescence","volume":"6","author":"Zhang","year":"2025","journal-title":"MedComm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/ijms22020590","article-title":"Molecular aspects of senescence and organismal ageing\u2014DNA damage response, telomeres, inflammation and chromatin","volume":"22","author":"S\u0142awi\u0144ska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"zpae077","DOI":"10.1093\/sleepadvances\/zpae077","article-title":"Sex-specific dementia risk in known or suspected obstructive sleep apnea: a 10-year longitudinal population-based study","volume":"5","author":"Braley","year":"2024","journal-title":"Sleep Adv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/cells8121501","article-title":"Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents","volume":"8","author":"Bojko","year":"2019","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2018.06.007","article-title":"PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells","volume":"34","author":"Georgilis","year":"2018","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/ger061","article-title":"Society, 29 th June\u20131 st July 2011. Held jointly with the Association for Radiation Research at the University of Nottingham, UK","volume":"27","author":"Phillips","year":"2012","journal-title":"Mutagenesis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10555-025-10302-1","article-title":"The intricate interplay between circadian rhythm, androgen signaling, hormone therapy, and cellular senescence in prostate cancer","volume":"44","author":"Heidari Horestani","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"114765","DOI":"10.1016\/j.bcp.2021.114765","article-title":"Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy","volume":"193","author":"Carpenter","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.3390\/cells11234026","article-title":"Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer","volume":"11","author":"Pardella","year":"2022","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2355","article-title":"p28-mediated activation of p53 in G2\u2013M phase of the cell cycle enhances the efficacy of DNA damaging and antimitotic chemotherapy","volume":"76","author":"Yamada","year":"2016","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.12.6166","article-title":"Targeting prostate cancer based on signal transduction and cell cycle pathways","volume":"7","author":"Lee","year":"2008","journal-title":"Cell Cycle"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.3390\/cancers13122944","article-title":"Response to androgens and androgen receptor antagonists in the presence of cytokines in prostate cancer","volume":"13","author":"Culig","year":"2021","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.33594\/000000671","article-title":"Mechanisms of senescence in cancer: positive and negative aspects of cancer cells senescence","volume":"57","author":"Zaczek","year":"2023","journal-title":"Cell Physiol Biochem"},{"key":"B26","doi-asserted-by":"publisher","first-page":"04","DOI":"10.1101\/2021.04.14.439569","article-title":"Transcriptional inactivation of TP53 and the BMP pathway mediates therapy-induced dedifferentiation and metastasis in prostate cancer","volume":"2021","author":"Han","year":"2021","journal-title":"bioRxiv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2407-12-145","article-title":"Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells","volume":"12","author":"Phillip","year":"2012","journal-title":"BMC cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33052","article-title":"Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat","volume":"10","author":"El Omari","year":"2024","journal-title":"Heliyon"},{"key":"B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/fon-2019-0745","article-title":"Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy","volume":"16","author":"Cimadamore","year":"2020","journal-title":"Taylor Francis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/dna4040036","article-title":"Cell senescence and the DNA single-strand break damage repair pathway","volume":"4","author":"Sarma","year":"2024","journal-title":"DNA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143814","article-title":"Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1\/p300\/p53\/p21 pathway","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.705903","article-title":"Remodeling the epigenetic landscape of cancer\u2014application potential of flavonoids in the prevention and treatment of cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.12.002","article-title":"Emerging epigenetic insights into aging mechanisms and interventions","volume":"45","author":"Wu","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12943-025-02419-2","article-title":"Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics","volume":"24","author":"Feng","year":"2025","journal-title":"Mol cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17933","article-title":"Overnight pulse rate variability and risk of major neurocognitive disorder in older patients with obstructive sleep apnea","volume":"70","author":"Sabil","year":"2022","journal-title":"J Am Geriatrics Soc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.14336\/AD.2024.0421","article-title":"Cellular aging and senescence in cancer: A holistic review of cellular fate determinants","volume":"16","author":"Tufail","year":"2024","journal-title":"Aging dis"},{"key":"B37","article-title":"Senescence-associated secretory phenotype regulated by mTOR pathway in senescent cells","author":"Maslyaeva","year":"2024"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00888-z","article-title":"Role of chemokines in the crosstalk between tumor and tumor-associated macrophages","volume":"23","author":"Qin","year":"2023","journal-title":"Clin Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7943","DOI":"10.3390\/ijms25147943","article-title":"Cellular senescence and extracellular vesicles in the pathogenesis and treatment of obesity\u2014A narrative review","volume":"25","author":"Liang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.7150\/thno.112633","article-title":"The role of senescence, its therapeutic relevance and clinical implications in the tumor microenvironment","volume":"15","author":"Shi","year":"2025","journal-title":"Theranostics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2345","article-title":"Biomarker technologies to support early clinical immuno-oncology development: advances and interpretation","volume":"27","author":"Cannarile","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S543211","article-title":"Targeting cellular senescence for healthy aging: advances in senolytics and senomorphics","volume":"19","author":"Alum","year":"2025","journal-title":"Drug Design Dev Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/antiox14080987","article-title":"Oxidative stress-driven cellular senescence: mechanistic crosstalk and therapeutic horizons","volume":"14","author":"Stojanovic","year":"2025","journal-title":"Antioxidants"},{"key":"B44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41568-024-00772-w","article-title":"Androgen receptor signalling in non-prostatic Malignancies: challenges and opportunities","volume":"25","author":"Dotto","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3724\/abbs.2022153","article-title":"Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape: DDR inhibitors, radiotherapy and immunotherapy can kill cancer cells","volume":"54","author":"Qiu","year":"2022","journal-title":"Acta Biochim Biophys Sinica"},{"key":"B46","doi-asserted-by":"publisher","first-page":"88211","DOI":"10.18632\/oncotarget.21656","article-title":"Molecular determinants of prostate cancer metastasis","volume":"8","author":"Rycaj","year":"2017","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41368-025-00380-w","article-title":"Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy","volume":"17","author":"Luo","year":"2025","journal-title":"Int J Oral Sci"},{"key":"B48","article-title":"The dynamic role of the androgen receptor (AR) and ABL interactor-1 (ABI1) axis in prostate cancer","author":"Porter","year":"2022"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71223","article-title":"Cellular senescence and immunosenescence in melanoma: insights from the tumor microenvironment","volume":"14","author":"Xiong","year":"2025","journal-title":"Cancer Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01867-y","article-title":"Immunopharmacology of senescence: targeting the senescence-associated secretory phenotype (SASP)\u2014a mechanism-based review","volume":"33","author":"Sahu","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/1061186X.2023.2295222","article-title":"Cancer stem cell biomarkers and related signalling pathways","volume":"32","author":"Wang","year":"2024","journal-title":"J Drug Targeting"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.3390\/biomedicines10112988","article-title":"Cancer metastasis and treatment resistance: mechanistic insights and therapeutic targeting of cancer stem cells and the tumor microenvironment","volume":"10","author":"Kilmister","year":"2022","journal-title":"Biomedicines"},{"key":"B53","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/cells14080608","article-title":"SASP modulation for cellular rejuvenation and tissue homeostasis: therapeutic strategies and molecular insights","volume":"14","author":"Alqahtani","year":"2025","journal-title":"Cells"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1772","article-title":"Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes","volume":"14","author":"Xiong","year":"2024","journal-title":"Clin Trans Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13312","article-title":"Targeting senescence as an anticancer therapy","volume":"16","author":"Bousset","year":"2022","journal-title":"Mol Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3892\/ol.2025.15338","article-title":"Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations","volume":"30","author":"Lam","year":"2025","journal-title":"Oncol Letters"},{"key":"B57","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/biom15060860","article-title":"Targeting senescence: A review of senolytics and senomorphics in anti-aging interventions","volume":"15","author":"Saliev","year":"2025","journal-title":"Biomolecules"},{"key":"B58","article-title":"Prognostic implications of cellular senescence in acute myeloid leukemia","author":"Sch\u00f6nlein","year":"2022"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2024.0589","article-title":"Senescent macrophages in cancer: roles in tumor progression and treatment opportunities","volume":"22","author":"Wang","year":"2025","journal-title":"Cancer Biol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol Rev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22806","article-title":"Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis","volume":"227","author":"Yang","year":"2012","journal-title":"J Cell Physiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal transduct targeted Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3390\/ijms23084109","article-title":"Cell senescence and central regulators of immune response","volume":"23","author":"Lunin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/biology9120485","article-title":"The senescence-associated secretory phenotype (SASP) in the challenging future of cancer therapy and age-related diseases","volume":"9","author":"Cuollo","year":"2020","journal-title":"Biology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10522-022-09937-w","article-title":"Tackling cellular senescence by targeting miRNAs","volume":"23","author":"Wang","year":"2022","journal-title":"Biogerontology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.15054","article-title":"Recent advances in biomarkers for senescence: Bridging basic research to clinic","volume":"25","author":"Fukumoto","year":"2025","journal-title":"Geriatrics Gerontol Int"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1743564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:28:47Z","timestamp":1771932527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1743564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":66,"alternative-id":["10.3389\/fonc.2026.1743564"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1743564","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1743564"}}